

Can't find Ceftriaxone? Learn about effective alternative antibiotics like Cefotaxime, Cefepime, and Ertapenem that your doctor may prescribe instead.
You've been prescribed Ceftriaxone — one of the most widely used injectable antibiotics in the U.S. — but your pharmacy, hospital, or clinic can't get it. Now what?
The ongoing Ceftriaxone shortage has forced doctors and patients to explore alternatives. The good news: there are effective substitutes for most infections that Ceftriaxone treats. In this guide, we'll explain what Ceftriaxone does, how it works, and which alternatives your doctor might consider.
Ceftriaxone (formerly sold as the brand-name drug Rocephin) is a third-generation cephalosporin antibiotic. It's given by injection — either intravenously (into a vein) or intramuscularly (into a muscle). Doctors prescribe it for a broad range of bacterial infections, including:
For a complete overview, see our post on what Ceftriaxone is and what it's used for.
Ceftriaxone works by interfering with bacterial cell wall synthesis. It binds to proteins called penicillin-binding proteins (PBPs) on the surface of bacteria, which disrupts the construction and repair of the cell wall. Without an intact cell wall, bacteria can't survive — they swell and burst.
This mechanism is shared by all cephalosporin and penicillin-type antibiotics, which is why several related drugs can serve as alternatives. For a more detailed explanation, read our guide on how Ceftriaxone works.
Cefotaxime is the closest alternative to Ceftriaxone. It's also a third-generation cephalosporin with a very similar spectrum of antibacterial activity. Here's how they compare:
Cefotaxime is a strong option for meningitis, pneumonia, UTIs, and many of the same infections Ceftriaxone treats. However, it may also face its own supply limitations during broad antibiotic shortages.
Cefepime is a fourth-generation cephalosporin that offers broader coverage than Ceftriaxone, including activity against Pseudomonas aeruginosa — a bacterium that Ceftriaxone doesn't reliably cover.
Your doctor might choose Cefepime if Ceftriaxone is unavailable and the infection requires reliable gram-negative coverage.
Ampicillin-Sulbactam is a combination of a penicillin-type antibiotic and a beta-lactamase inhibitor. It's effective against many of the same organisms as Ceftriaxone, plus some anaerobic bacteria.
Ertapenem is a carbapenem antibiotic — a class of drugs with very broad antibacterial activity. It's considered a step up from cephalosporins and is typically reserved for more resistant infections.
The right alternative depends on:
This is a decision you and your doctor should make together. Don't switch antibiotics on your own or stop treatment because one medication is unavailable. Always talk to your healthcare provider about the best option for your specific situation.
The Ceftriaxone shortage is frustrating, but it doesn't mean you're out of options. Cefotaxime, Cefepime, Ampicillin-Sulbactam, and Ertapenem are all proven antibiotics that can effectively treat many of the same infections.
Before switching, check Medfinder to see if Ceftriaxone is available near you — sometimes the medication is in stock at a nearby pharmacy or clinic you haven't tried yet. You can also read our guide on how to find Ceftriaxone in stock near you for more tips.
If switching is the right move, talk to your doctor about which alternative makes the most sense for your infection. And for information on potential drug interactions or side effects of any antibiotic, we've got you covered.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.